11-56318619-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001005202.2(OR8K3):c.313C>T(p.Leu105Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000235 in 1,613,646 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001005202.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR8K3 | NM_001005202.2 | c.313C>T | p.Leu105Phe | missense_variant | 3/3 | ENST00000641662.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR8K3 | ENST00000641662.1 | c.313C>T | p.Leu105Phe | missense_variant | 3/3 | NM_001005202.2 | P1 | ||
OR8K3 | ENST00000641689.1 | c.313C>T | p.Leu105Phe | missense_variant | 2/2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152132Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000438 AC: 11AN: 250896Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135602
GnomAD4 exome AF: 0.00000889 AC: 13AN: 1461514Hom.: 0 Cov.: 32 AF XY: 0.00000825 AC XY: 6AN XY: 727060
GnomAD4 genome AF: 0.000164 AC: 25AN: 152132Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74336
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 02, 2022 | The c.313C>T (p.L105F) alteration is located in exon 1 (coding exon 1) of the OR8K3 gene. This alteration results from a C to T substitution at nucleotide position 313, causing the leucine (L) at amino acid position 105 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at